5.7058
price down icon1.13%   -0.0642
 
loading
전일 마감가:
$5.77
열려 있는:
$5.75
하루 거래량:
598.94K
Relative Volume:
0.48
시가총액:
$589.57M
수익:
-
순이익/손실:
$-168.09M
주가수익비율:
-2.6294
EPS:
-2.17
순현금흐름:
$-138.01M
1주 성능:
-4.60%
1개월 성능:
+0.26%
6개월 성능:
-34.50%
1년 성능:
-73.09%
1일 변동 폭
Value
$5.5914
$5.88
1주일 범위
Value
$5.5914
$5.97
52주 변동 폭
Value
$5.41
$23.48

Kura Oncology Inc Stock (KURA) Company Profile

Name
명칭
Kura Oncology Inc
Name
전화
(858) 500-8800
Name
주소
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Name
직원
192
Name
트위터
@kuraoncology
Name
다음 수익 날짜
2025-02-21
Name
최신 SEC 제출 서류
Name
KURA's Discussions on Twitter

KURA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
KURA
Kura Oncology Inc
5.71 589.57M 0 -168.09M -138.01M -2.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
451.98 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
537.29 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
323.52 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
553.86 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.50 28.51B 3.81B -644.79M -669.77M -6.24

Kura Oncology Inc Stock (KURA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-06 다운그레이드 BTIG Research Buy → Neutral
2024-10-24 개시 UBS Buy
2024-10-14 다운그레이드 Stifel Buy → Hold
2023-12-22 개시 Mizuho Buy
2023-08-11 개시 BofA Securities Buy
2023-07-27 개시 Scotiabank Sector Perform
2023-05-17 개시 BTIG Research Buy
2023-01-31 개시 Stifel Buy
2022-07-12 개시 Cantor Fitzgerald Overweight
2022-02-15 개시 Jefferies Buy
2021-05-05 재개 Credit Suisse Outperform
2021-04-26 재개 Credit Suisse Outperform
2020-12-07 재확인 H.C. Wainwright Buy
2020-12-03 개시 Stifel Buy
2020-11-05 다운그레이드 Piper Sandler Overweight → Neutral
2020-07-07 개시 Credit Suisse Outperform
2020-05-05 개시 Barclays Overweight
2019-07-18 개시 Deutsche Bank Buy
2018-11-09 개시 Piper Jaffray Overweight
2018-08-01 개시 H.C. Wainwright Buy
2016-10-13 재개 Leerink Partners Outperform
2016-01-22 개시 JMP Securities Mkt Outperform
2015-12-30 개시 Oppenheimer Outperform
2015-12-16 개시 Citigroup Buy
모두보기

Kura Oncology Inc 주식(KURA)의 최신 뉴스

pulisher
Jun 18, 2025

Transcript : Kura Oncology, Inc.Special Call - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Kura Oncology Announces Positive Phase 1a/1b Trial Results - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Long Term Trading Analysis for (KURA) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 17, 2025

Kura Oncology rises after new early-stage trial data for leukemia therapy - MSN

Jun 17, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Invests $66,000 in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Sold by Harbor Capital Advisors Inc. - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook - Investing.com Canada

Jun 13, 2025
pulisher
Jun 12, 2025

KURA's Ziftomenib Shows Promising Results in AML Clinical Trial - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology reports positive data for AML treatment ziftomenib By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Is the Options Market Predicting a Spike in Kura Oncology Stock? - The Globe and Mail

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology (KURA) Shows Promising Results for AML Therapy - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology Says Ziftomenib Study Achieves Complete Remission in Acute Myeloid Leukemia - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology stock rises on leukemia drug data (KURA:NASDAQ) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

Is The Options Market Predicting A Spike In Kura Oncology Stock? - Barchart.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combinatio - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology’s SWOT analysis: ziftomenib stock potential in AML treatment By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Strong Results from KOMET-007 Trial of Ziftomenib in Newly Diagnosed AML Patients - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology reports positive data for AML treatment ziftomenib - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly ... - Enidnews.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology’s SWOT analysis: ziftomenib stock potential in AML treatment - Investing.com

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Forecasts Kura Oncology FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

KURA Stock Rises More Than 15% This Past Week: Here's Why - MSN

Jun 11, 2025
pulisher
Jun 10, 2025

Kura Oncology at Goldman Sachs Conference: Strategic Insights on ZIFTOMENIB - Investing.com Canada

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Kura Oncology, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 11 - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Acquires New Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Kura Oncology Stockholders Approve Equity Plan Amendment - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Grants Stock Options To New Hires Under Inducement Plan - Nasdaq

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rul - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology (KURA) Grants Stock Options to New Employees | KUR - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology (KURA) Grants Stock Options to New Employees | KURA Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | KURA Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

Jun 06, 2025
pulisher
Jun 06, 2025

Kura Oncology Expands Cancer Research Team with Strategic Stock Options for 5 Key New Hires - Stock Titan

Jun 06, 2025
pulisher
Jun 05, 2025

Kura Oncology’s (KURA) “Market Outperform” Rating Reaffirmed at JMP Securities - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Kura Oncology at Jefferies Conference: Strategic Advancements in AML By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

**citizens jmp reiterates market outperform rating on kura oncology stock** - Investing.com UK

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Investments LP Sells 42,120 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Rising Leaders 2025: Kura Oncology’s Mollie Leoni On Setting Precedent, Not Following It - insights.citeline.com

Jun 04, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Lowers Stock Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Transcript : Kura Oncology, Inc. Presents at American Society of Clinical Oncology Annual Meeting 2025, Jun-02-2025 06 - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Kura Oncology Drug’s Data at ASCO Support FDA Filing Now Under Priority Review for Leukemia - MedCity News

Jun 03, 2025
pulisher
Jun 03, 2025

KURA: Optimism for Kura Oncology's Menin Inhibitor Grows with FDA Priority Review | KURA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Cantor Fitzgerald reiterates overweight rating for Kura Oncology stock By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

Kura Oncology reports positive trial results for AML treatment By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

Kura Oncology at ASCO: Strategic Moves in AML Treatment By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 02, 2025

Kura Oncology reports positive trial results for AML treatment - Investing.com Australia

Jun 02, 2025
pulisher
Jun 02, 2025

KURA: Promising Results for Kura Oncology's AML Therapy at ASCO Meeting | KURA Stock News - GuruFocus

Jun 02, 2025

Kura Oncology Inc (KURA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Kura Oncology Inc 주식 (KURA) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
FORD KATHLEEN
Chief Operating Officer
May 19 '25
Sale
6.28
1,558
9,777
21,367
$20.87
price up icon 0.99%
$35.78
price down icon 0.78%
$21.44
price up icon 0.99%
$98.77
price down icon 2.03%
$108.80
price up icon 2.21%
biotechnology ONC
$245.50
price up icon 1.42%
자본화:     |  볼륨(24시간):